Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: other route
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: only secondary literature available

Data source

Referenceopen allclose all

Reference Type:
other: cited in BG Chemie 2000
Title:
Toxicity of a rubber accelerator
Author:
Guess, W., L.; et al.
Year:
1969
Bibliographic source:
Toxicol. Appl. Pharmacol., 14, 221-231
Reference Type:
publication
Title:
Toxikologische Bewertung 2-Mercaptobenzothiazol, Nr. 70, CAS Nr. 149-30-4
Author:
BG Chemie
Year:
2000
Bibliographic source:
Berufsgenossenschaft der chemischen Industrie, ISSN 0937-4248

Materials and methods

Principles of method if other than guideline:
other: subacute toxicity study

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzothiazole-2-thiol
EC Number:
205-736-8
EC Name:
Benzothiazole-2-thiol
Cas Number:
149-30-4
Molecular formula:
C7H5NS2
IUPAC Name:
1,3-benzothiazole-2-thiol
Details on test material:
MBT

Test animals

Species:
mouse

Administration / exposure

Route of administration:
intraperitoneal
Duration of treatment / exposure:
1 week
Frequency of treatment:
daily
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 55, 110 mg/kg bw
No. of animals per sex per dose:
10 per dose
Control animals:
yes

Results and discussion

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

Gross pathology: no effects

Effects on the liver and kidney, no effects on lung, heart, testis and thyroid gland

hexobarbital-induced sleeping phase extended

Applicant's summary and conclusion